分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Lacticaseibacillus rhamnosus 1.0320 isolated from fermented kumis combined with 3-Fucosyllactose and 3'-Sialyllactose ameliorates LPS-induced intestinal epithelial barrier dysfunction by inhibiting the NF-κB pathway and activating the Nrf2 pathway

Xiaolei Duan, Hao Shi, Mingzhang Zhao, Zhanmei Jiang, Jing Zhang, Xianhui Chen, He Zhang, Juncai Hou, Xiangyu Li

Journal:INTERNATIONAL DAIRY JOURNAL

IF:3.4

DOI:10.1016/j.idairyj.2025.106545

PMID:

Published:2026-01-02

research field:肿瘤学神经科学细胞生物学

Abstract

Intestinal epithelial barrier function is vital to gut homeostasis. This study investigated the effects of Lacticaseibacillus rhamnosus 1.0320 combined with 3-FL and 3'-SL using the LPS-induced barrier injury model. The results showed that the combination of 3-FL, 3'-SL, and L. rhamnosus 1.0320 significantly enhanced the levels of GSH, SOD and CAT, reduced the levels of pro-inflammatory cytokine. Meanwhile, the combination ameliorated intestinal epithelial barrier dysfunction by upregulating expression levels of tight junction (TJ) protein. The underlying mechanism was that the combination inhibited the TLR4/NF-κB pathway by reducing MyD88 expression and NF-κB p65 phosphorylation. Meanwhile, the combination activated the Nrf2/NQO-1 signaling pathway by promoting Nrf2 nuclear translocation. Additionally, L. rhamnosus 1.0320 combined with 3-FL and 3'-SL reduced apoptosis by modulating the expression ratio of Bcl-2/Bax. These findings would provide a combined strategy for the development of functional foods to ameliorate intestinal barrier dysfunction.

本文使用的Yeasen产品

购物车
客服
转染试用